All Stories

  1. Investigating the predictive role of inflammatory indices in cancer metastasis
  2. Immune System‐Related Genetic Risk Factors for Inhibitory Antibody Development in Patients With Hemophilia: Reviewing an Old Problem From a New Perspective—A Narrative Review
  3. The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia
  4. Assessment of rs1205 and rs1130864 Polymorphisms of C‐Reactive Protein Gene (CRP) and Serum CRP Levels in Immune Thrombocytopenia: A Case‐Control Study
  5. Update Prognostic Potency of Vascular Endothelial Growth Factor‐A in the Acute Lymphoblastic Leukemia Landscape: A Meta‐Analysis
  6. Missense and nonsense mutations and inhibitor development in patients with hemophilia A and B
  7. The Association of Serum Level of TGF‐β1 and Clinical Manifestations in Sickle Cell Anemia: A Case‐Control Study
  8. Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma
  9. Evaluation of Complete Blood Count Parameters in Patients With Diabetes Mellitus: A Systematic Review
  10. The Association of Nasal and Blood Eosinophils with Serum IgE Level in Allergic Rhinitis and Asthma: A Case‐Control Study
  11. Evaluation of Pro‐BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case–control study
  12. DNA damage repair in megakaryopoiesis: molecular and clinical aspects
  13. Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process
  14. The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals
  15. The prognostic potential of long noncoding RNA XIST in cardiovascular diseases: a review
  16. A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia
  17. Emerging Roles of HOTAIR LncRNA in the Pathogenesis and Prognosis of Cardiovascular Diseases
  18. Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis
  19. lncRNA TUG1 as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases
  20. rs1800890 Polymorphism of IL-10 and Susceptibility to Idiopathic Thrombocytopenic Purpura
  21. Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
  22. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID‐19 patients: A systematic review and meta‐analysis
  23. Association of human papillomavirus with breast cancer: a new perspective on an old debate
  24. Application of Bayesian Decision Tree in Hematology Research: Differential Diagnosis of β-Thalassemia Trait from Iron Deficiency Anemia
  25. Aplastic anemia, cellular and molecular aspects
  26. Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches
  27. The effect of inflammatory factors and their inhibitors on the hematopoietic stem cells fate
  28. Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application
  29. Chemo/radiotherapy-Induced Bone Marrow Niche Alterations
  30. The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease
  31. Co-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach
  32. Prognostic role and therapeutic susceptibility of cathepsin in various types of solid tumor and leukemia: A systematic review
  33. T-Cell Molecular Modulation Responses in Atherosclerosis Anergy
  34. Epigenetic modifications and transcriptional networks in leukemic transformation of HSCs
  35. STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia
  36. Investigation of JAK2V617F Mutation Prevalence in Patients with Beta Thalassemia Major
  37. Cardiomyopathy in Thalassemia: Quick Review from Cellular Aspects to Diagnosis and Current Treatments
  38. Expression of Blood Cells Associated CD Markers and Cardiovascular Diseases: Clinical Applications in Prognosis
  39. Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
  40. Neutropenia and leukemia development: genetic risk factors and prognosis
  41. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties
  42. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis
  43. Involvement of Interferon‐γ + 874A/T Polymorphism in the Pathogenesis of and Therapeutic Response to Immune Thrombocytopenia
  44. Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia
  45. Role of bone marrow adipocytes in leukemia and chemotherapy challenges
  46. T‐bet transcription factor in cardiovascular disease: Attenuation or inflammation factor?
  47. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease
  48. Protective role of heat shock transcription factor 1 in heart failure: A diagnostic approach
  49. Signaling-chemokine axis network in brain as a sanctuary site for metastasis
  50. Platelet Activation Polymorphisms in Ischemia
  51. Cellular expression of CD markers in immune thrombocytopenic purpura: implications for prognosis
  52. Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach
  53. Oxidative stress in normal hematopoietic stem cells and leukemia
  54. JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms
  55. Cardiovascular disease cause challenge in hematologic cancers
  56. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response
  57. How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients?
  58. Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide- induced acute liver damage in mice
  59. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients
  60. BCR/ABL analysis in myelodysplastic syndromes
  61. Restoration of natural killer cell cytotoxicity in the suppressive tumor microenvironment: novel approaches to treat AML
  62. Evaluation of miR-21 and miR-150 expression in immune thrombocytopenic purpura pathogenesis: a case-control study
  63. Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches
  64. Sex chromosome changes in leukemia: cytogenetics and molecular aspects
  65. Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature
  66. Association between beta globin haplotypes, HBBP1 and HMOX1 polymorphisms in relation to HbF among sickle cell anemia patients: a study in Southwest Iran
  67. tree-based methods for differential diagnosis of hematologic disorders
  68. An association study between CHEK2 gene mutations and susceptibility to breast cancer
  69. Prognostic significance of aberrant expression of CD markers in acute lymphoblastic leukemia
  70. Crosstalk between catecholamines and erythropoiesis
  71. The role and clinical implications of the endosteal niche and osteoblasts in regulating leukemia
  72. MicroRNAs as prognostic biomarker and relapse indicator in leukemia
  73. PD-1/PD-L1 as a prognostic factor in leukemia
  74. Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis
  75. Association between microRNA-21, microRNA-150, and micro-RNA-451 expression and clinical outcome of patients with acute lymphoblastic leukemia
  76. Analysis of DNA methyltransferase 3A gene mutations in patients with Philadelphia-negative myeloproliferative neoplasms
  77. Role of oxidative stress in liver cancer
  78. Sequencing myeloproliferative leukemia exon 10 mutations in iranian patients with breakpoint cluster region-abelson murine leukemia viral oncogene homolog 1-negative myeloproliferative neoplasm
  79. Bone marrow blood vessels: normal and neoplastic niche
  80. High platelet count and high probability of CALR detection in myeloproliferative neoplasms
  81. Acute myeloid leukemia in the vascular niche
  82. Incidence of T315I mutation in BCR/ABL-positive CML and ALL patients
  83. Regulatory role of Megakaryocytes on Hematopoietic Stem Cells Quiescence by CXCL4/PF4 in Bone Marrow Niche
  84. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells
  85. Cytogenetic changes of mesenchymal stem cells in the neoplastic bone marrow niche in leukemia
  86. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis
  87. Role of stem cell factor in the placental niche
  88. Significance of oncogenes and tumor suppressor genes in AML prognosis
  89. A cocktail of repurposed drugs for targeted therapy of glioblastoma
  90. Is Wilms’ tumor gene 1 a useful biomarker for detecting minimal residual disease in chronic myeloid leukemia (BCR-ABL1-p210-positive) patients?
  91. Evaluation of α-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran
  92. Evaluation of microRNA-146a expression in acute lymphoblastic leukemia
  93. Stem Cell Therapy ‒ Approach for Multiple Sclerosis Treatment
  94. Is There a Relationship Between CXCR4 Gene Expression and Prognosis of Immune Thrombocytopenia in Children?
  95. Signaling and molecular basis of bone marrow niche angiogenesis in leukemia
  96. Coexistence of P190 BCR/ABL transcript and CALR 52-bp deletion in chronic myeloid leukemia blast crisis: a case report
  97. Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche
  98. Prognostic value and clinical significance of TCR rearrangements for MRD monitoring in ALL patients
  99. Survivin and SIRT1: can be two prognostic factors in chronic myeloid leukemia?
  100. Wnt/β-catenin signaling in bone marrow niche
  101. Inhibition of Ras-mediated signaling pathways in CML stem cells
  102. Bone marrow niche in the myelodysplastic syndromes
  103. Central nervous system niche involvement in the leukemia
  104. MicroRNAs in erythropoiesis and red blood cell disorders
  105. Twist as a new prognostic marker in hematological malignancies
  106. The Influence of Polymorphisms in Disease Severity in β-Thalassemia
  107. The bone marrow metastasis niche in retinoblastoma
  108. Immunophenotype, microRNA expression and cytogenetic characterization of acute leukemias of ambiguous lineage
  109. Rare cytogenetic abnormalities and alteration of microRNAs in acute myeloid leukemia and response to therapy
  110. Regulatory effect of chemokines in bone marrow niche
  111. Targeting PI3K/AKT/mTOR network for treatment of leukemia
  112. The mechanistic role of epigenetic in multiple myeloma
  113. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
  114. G-CSF induces up-regulation of CXCR4 expression in human hematopoietic stem cells by beta-adrenergic agonist
  115. A case of chronic lymphoblastic leukemia with an abnormal rare karyotype
  116. The role of Pax5 in leukemia: diagnosis and prognosis significance
  117. Hodgkin’s lymphoma after 2-month infliximab therapy: case report
  118. Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches
  119. BRAF mutation in hairy cell leukemia
  120. New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
  121. PCR Analysis of IgH and TCR-γ Gene Rearrangements as a Confirmatory Diagnostic Tool for Lymphoproliferative Disorders
  122. The role of notch signaling in bone marrow niche
  123. Induction of Fetal Hemoglobin as a Novel Therapeutic Strategy for β-Hemoglobinopathy
  124. Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia
  125. Frequency of β-Thalassemia or β-Hemoglobinopathy Carriers Simultaneously Affected with α-Thalassemia in Iran
  126. Prooxidant-Antioxidant Balance and hs-CRP in Patients with β-Thalassemia Major
  127. The role of microRNAs in stemness of cancer stem cells
  128. Meta-analysis of Genetic Polymorphisms and Ophthalmologic Disease Risk in Asian Populations: a Case of DNA Repair XRCC1 Gene
  129. Bone marrow neoplastic niche in leukemia
  130. The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts
  131. The Role of the Nervous System in Hematopoietic Stem Cell Mobilization
  132. Does DNA Methylation Plays a Critical Role in Osteoblastic Differentiation of Mesenchymal Stem Cells (MSCs)?
  133. Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer
  134. Evaluation of H3 Histone Methylation and Colony Formation in Erythroid Progenitors Treated with Thalidomide and Sodium Butyrate
  135. JAK2 V617F Mutation in Iranian Patients with Myeloproliferative Neoplasms: Clinical and Laboratory Findings
  136. Biology and Bioinformatics of Myeloma Cell
  137. The first report of homozygous May-Hegglin anomaly E1841K mutation